• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ivabradine for the Therapy of Chronic Stable Angina Pectoris.

作者信息

Kim Soo Joong

机构信息

Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul, Korea.

出版信息

Korean Circ J. 2020 Sep;50(9):787-790. doi: 10.4070/kcj.2020.0266.

DOI:10.4070/kcj.2020.0266
PMID:32812408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7441002/
Abstract
摘要

相似文献

1
Ivabradine for the Therapy of Chronic Stable Angina Pectoris.伊伐布雷定用于慢性稳定性心绞痛的治疗。
Korean Circ J. 2020 Sep;50(9):787-790. doi: 10.4070/kcj.2020.0266.
2
Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.伊伐布雷定对稳定型心绞痛患者内皮功能的影响：使用Endo-PAT 2000设备进行评估。
Adv Ther. 2015 Oct;32(10):962-70. doi: 10.1007/s12325-015-0253-x. Epub 2015 Nov 2.
3
Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.根据基线心率评估比索洛尔治疗稳定型心绞痛患者中伊伐布雷定的疗效：ASSOCIATE 研究分析。
Int J Cardiol. 2013 Sep 30;168(2):789-94. doi: 10.1016/j.ijcard.2012.10.011. Epub 2012 Nov 6.
4
Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.伊伐布雷定（一种选择性 I(f)抑制剂）在慢性稳定型心绞痛伴糖尿病患者中的疗效。
Am J Cardiol. 2010 Jan 1;105(1):29-35. doi: 10.1016/j.amjcard.2009.08.642. Epub 2009 Nov 10.
5
The Role of Ivabradine in the Management of Angina Pectoris.伊伐布雷定在心绞痛管理中的作用。
Cardiovasc Drugs Ther. 2016 Aug;30(4):407-417. doi: 10.1007/s10557-016-6678-x.
6
Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.伊伐布雷定联合或不联合β受体阻滞剂治疗慢性稳定性心绞痛患者在常规临床实践中的有效性和耐受性
Adv Ther. 2016 Sep;33(9):1550-64. doi: 10.1007/s12325-016-0377-7. Epub 2016 Jul 18.
7
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.伊伐布雷定与氨氯地平治疗稳定型劳力性心绞痛患者的抗心绞痛疗效及安全性比较：一项为期3个月的随机、双盲、多中心、非劣效性试验
Drugs. 2007;67(3):393-405. doi: 10.2165/00003495-200767030-00005.
8
Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.伊伐布雷定联合β受体阻滞剂可减轻老年稳定型心绞痛患者的症状并改善生活质量：ADDITIONS研究的年龄相关结果
Exp Gerontol. 2014 Nov;59:34-41. doi: 10.1016/j.exger.2014.09.002.
9
Ivabradine for the Therapy of Chronic Stable Angina Pectoris: a Systematic Review and Meta-Analysis.伊伐布雷定治疗慢性稳定性心绞痛：一项系统评价和荟萃分析。
Korean Circ J. 2020 Sep;50(9):773-786. doi: 10.4070/kcj.2020.0031. Epub 2020 May 20.
10
[A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris].
Ter Arkh. 2013;85(4):77-83.

本文引用的文献

1
Ivabradine for the Therapy of Chronic Stable Angina Pectoris: a Systematic Review and Meta-Analysis.伊伐布雷定治疗慢性稳定性心绞痛：一项系统评价和荟萃分析。
Korean Circ J. 2020 Sep;50(9):773-786. doi: 10.4070/kcj.2020.0031. Epub 2020 May 20.
2
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
3
Ivabradine in stable coronary artery disease without clinical heart failure.稳定性冠状动脉疾病且无临床心力衰竭的伊伐布雷定。
N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.
4
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.依伐布雷定联合β受体阻滞剂改善稳定性心绞痛患者的症状和生活质量：ADDITIONS 研究结果。
Clin Res Cardiol. 2012 May;101(5):365-73. doi: 10.1007/s00392-011-0402-4. Epub 2012 Jan 10.
5
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.If电流抑制剂伊伐布雷定在接受β受体阻滞剂治疗的慢性稳定型心绞痛患者中的疗效：一项为期4个月的随机安慰剂对照试验。
Eur Heart J. 2009 Mar;30(5):540-8. doi: 10.1093/eurheartj/ehn571. Epub 2009 Jan 9.
6
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.伊伐布雷定用于稳定型冠状动脉疾病和左心室收缩功能障碍患者（BEAUTIFUL）：一项随机、双盲、安慰剂对照试验。
Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.
7
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.伊伐布雷定与氨氯地平治疗稳定型劳力性心绞痛患者的抗心绞痛疗效及安全性比较：一项为期3个月的随机、双盲、多中心、非劣效性试验
Drugs. 2007;67(3):393-405. doi: 10.2165/00003495-200767030-00005.
8
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.新型选择性If抑制剂伊伐布雷定与阿替洛尔治疗慢性稳定性心绞痛患者的疗效比较
Eur Heart J. 2005 Dec;26(23):2529-36. doi: 10.1093/eurheartj/ehi586. Epub 2005 Oct 7.
9
Physiology and pharmacology of the cardiac pacemaker ("funny") current.心脏起搏器（“起搏”）电流的生理学与药理学
Pharmacol Ther. 2005 Jul;107(1):59-79. doi: 10.1016/j.pharmthera.2005.01.005.
10
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.If电流抑制剂伊伐布雷定对稳定型心绞痛的抗心绞痛和抗缺血作用：一项随机、双盲、多中心、安慰剂对照试验
Circulation. 2003 Feb 18;107(6):817-23. doi: 10.1161/01.cir.0000048143.25023.87.